Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats

Behavioural Brain Research

Volumn 257, Issue , 2013, Pages 77-82

  Zangrando, Julia ^a   Carvalheira, Renata ^a   Labbate, Giovanna ^a   Medeiros, Priscila ^a   Longo, Beatriz Monteiro ^a   Melo Thomas, Liana ^a   Barbosa Silva, Regina Claudia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Inferior colliculus; MK 801; NMDA; Olanzapine; Prepulse inhibition; Schizophrenia

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLANZAPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUTAMATERGIC NEUROTRANSMISSION; INFERIOR COLLICULUS; MALE; NEUROTRANSMISSION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

INFERIOR COLLICULUS; MK-801; NMDA; OLANZAPINE; PREPULSE INHIBITION; SCHIZOPHRENIA;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; INFERIOR COLLICULI; MALE; MICROINJECTIONS; N-METHYLASPARTATE; PSYCHOACOUSTICS; RATS; RATS, WISTAR; SENSORY GATING; STARTLE REACTION;

EID: 84885415461     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.018     Document Type: Article

References (61)

1. Cilia J., Hatcher P., Reavill C., Jones D.N.C. (±) ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics. J Psychopharmacol 2007, 21:302-311.
2. Slot L.A.B., Kleven M.S., Newman-Tancredi A. Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the rat. Neuropharmacology 2005, 49:996-1006.
3. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:687-700.
4. Geyer M.A., Thomson K.K., Braff D., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensoriomotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156:117-154.
5. Gururajan A., Taylor D.A., Malone D.T. Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social bahaviour and locomotor activity. Physiol Behav 2010, 99:131-138.
6. Gururajan A., Taylor D.A., Malone D.T. Effect of cannabidiol in a MK-801 - rodent model of aspects of schizophrenia. Behav Brain Res 2011, 222:299-308.
7. Yang S.Y., Hong C.J., Huang Y.H., Tsai S.J. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on katamine-induced alterations in sesorimotor gating and regional brain c-Fos expression in rats. Neurosci Lett 2010, 469:127-130.
8. Rung J.P., Carlsson A., Markinhuhta K.R., Carlsson M.L. (+)-MK-801 induced social withdrawal in rats: a model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:833-839.
9. Mansbach R.S., Carver J., Zorn S.H. Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol Biochem Behav 2001, 69:535-542.
10. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci U S A 1986, 83:7104-7108.
11. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384.
12. Gururajan A., Taylor D.A., Malone D.T. Current pharmacological models of social withdrawal in rats: relevance to schizophrenia. Behav Pharmacol 2010, 21:690-709.
13. Kilts C.D. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 2001, 50:845-855.
14. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychophamacology 2001, 156:194-215.
15. Ouagazzal A., Nieoullon A., Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology 1993, 111:427-434.
16. BubenikovaV.Votava M., Horacek J., Palenicek T., Dockery C. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav 2005, 80:591-596.
17. Li L., Korngut L.M., Frost B.J., Beninger R.J. Prepulse inhibition following lesions of inferior colliculus: prepulse intensity functions. Physiol Behav 1998, 65:133-139.
18. Silva R.C.B., Sandner G., Brandão M.L. Unilateral electrical stimulation of the inferior colliculus of rats modifies the prepulse modulation of the startle response (PPI): effects of ketamine and diazepam. Behav Brain Res 2005, 160:323-330.
19. Fendt M., Li L., Yeomans J.S. Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology 2001, 156:216-224.
20. Leitner D.S., Cohen M.E. Role of the inferior colliculus in the inhibition of acoustic startle in the rat. Physiol Behav 1985, 34:65-70.
21. Saitoh K., Tilson H.A., Shaw S., Dver R.S. Possible role of the brainstem in the mediation of prepulse inhibition in the rat. Neurosci Lett 1987, 75:216-222.
22. Paxinos G., Watson G.C. The rat brain in stereotaxic coordinates 2007, Academic Press, New York. 3rd ed.
23. Brandão M.L., Melo L.L., Cardoso S.H. Mechanisms of defense in the inferior colliculus. Behav Brain Res 1993, 58:49-55.
24. Melo L.L., Santos P., Medeiros P., Mello O., Ferrari E.A.M., Brandao M.L., et al. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol induced-catalepsy. Brain Res 2010, 41-47.
25. Boyda H.N., Procyshyn R.M., Pang C.C., Hawkes E., Wong D., Jin C.H., et al. Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine. PLoS ONE 2013, 8:534-559.
26. Zhao C., Li M. Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fosimmuno reactivity. Pharmacol Biochem Behav 2012, 103:174-180.
27. Blomqvist A., Danielsson I., Norrsell U. The somatosensory intercollicular nucleus of the cat's mesencephalon. J Physiol 1990, 429:191-193.
28. Snell L.D., Yi S.J., Johnson K.M. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 1988, 145:223-226.
29. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 1989, 167:127-135.
30. Yan Q.S., Reith M.E., Jobe P.C., Dailey J.W. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 1997, 765:149-158.
31. Criswell H.E., Johnson K.B., Mueller R.A., Breese G.R. Evidencefor involvement of brain dopamine and other mechanisms in thebehavioral action of the N-methyl-d-aspartic acid antagonist MK-801in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 1993, 265:1001-1010.
32. Satake S., Yamada K., Melo L.L., Silva R.B. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on prepulse inhibition of the acoustic startle reflex in rat. Neurosci Lett 2012, 509:60-63.
33. Melo L.L., Pereira E., Pagini C., Coimbra N., Brandão M., Ferrari E. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response. Exp Neurol 2009, 216:16-21.
34. Basta-Kaim A., Fijat K., Budziszewska B., Regulska M., Leskiewicz M., Kubera M., et al. Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats. Pharmacol Biochem Behav 2011, 98:241-249.
35. Carlson M., Carlson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990, 13:272-276.
36. Akil M., Kolachana B.S., Rothmond D.A., Hyde T.M., Weinberger D.R., Kleinman J.E. Catechol-O-methyl transferase genotype and dopamine regulation in the human brain. J Neusrosci 2003, 23:2008-2013.
37. Akil M., Edgar C.L., Pierri J.N., Casali S., Lewis D.A. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiatry 2000, 47:361-370.
38. Wedzony K., Fijat K., Chocyk A. Blockade of NMDA receptors in postnatal period decreased density of tyrosine hydroxylase immune reactive axonal arbors in the medial prefrontal cortex of adult rats. J Physiol Pharmacol 2005, 56:205-221.
39. Dall'Olio R., Facchinetti F., Contestabile A., Gandolfi O. Chronic neonatal blockade of N-methyl-d-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat. Neuroscience 1994, 63:451-455.
40. Schneider M., Koch M. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Exp Neurol 2005, 195:185-188.
41. Watanabe M., Mishina M., Inoue Y. Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. J Comp Neurol 1994, 343:520-531.
42. Petralia R.S., Yokotani N., Wenthold R.J. Light and electronmicroscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 1994, 14:667-696.
43. Burger R.M., Pollak G.D. Analysis of the role of inhibition in shaping responses to sinusoidally amplitude-modulated signals in the inferior colliculus. J Neurophysiol 1998, 80:1686-1701.
44. Faingold C.L., Hoffman W.E., Caspary D.M. Effects of excitatory amino acids on acoustic responses of inferior colliculus neurons. Hear Res 1989, 40:127-136.
45. Fu X.W., Brezden B.L., Nelly J.B., Wu S.H. Synaptic excitation in the dorsal nucleus of the lateral lemniscus: whole-cell patch-clamp recordings from rat brain slice. Neuroscience 1997, 78:815-827.
46. Zhang H., Kelly J.B. AMPA and NMDA receptors regulate responses of neurons in the rat's inferior colliculus. J Neurophysiol 2001, 86:871-880.
47. Olazábal U.E., Moore J.K. Nigrotectal projection to the inferior colliculus: horseradish peroxidase transport andtyrosine hydroxylase immunohistochemical studies in rats, cats, and bats. J Comp Neurol 1989, 282:98-118.
48. Gerfen C.R., Staines W.A., Arbuthnott G.W., Fibiger H.C. Crossed connections of the sunstantia nigra in the rat. J Comp Neurol 1982, 207:283-303.
49. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organization of the basal ganglia. J Anat 2000, 196:527-542.
50. Castellan-Baldan L., da Costa-Kawasaki M., Ribeiro S.J., Calvo F., Corrêa V.M.A., Coimbra N.C. Topographic and functional neuroanatomical study of GABAergic disinhibitory striatum-nigral inputs and inhibitory nigrocollicular pathways: neural hodology recruiting the substantia nigra, pars reticulata, for the modulation of the neural activity in the inferior colliculus involved with panic-like emotions. J Chem Neuroanat 2006, 32:1-27.
51. Fallon J.J., Laughlin S.E. Substantia nigra. The rat nervous system 1995, 215-237. Academic Press, San Diego. G. Paxinos (Ed.).
52. Eichenberger G.C.D., Ribeiro S.J., Osaki M.Y., Maruoka R.Y., Resende G.C.C., Castellan-Baldan L., et al. Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray matter. Neuropharmacology 2002, 42:48-59.
53. Yasui Y., Nakano K., Kayahara T., Mizuno N. Non-dopaminergic projections from the substantia nigra pars lateralis to the inferior colliculus in the rat. Brain Res 1991, 559:139-144.
54. Moriizumi T., Hattori T. Pallidotectal projection to the inferior colliculus of the rat. Exp Brain Res 1991, 87:223-226.
55. Imperatore A., Honore T., Jensen L.H. Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res 1990, 530:223-228.
56. Young A.M.J., Bradford H.F. N-methyl-d-aspartate releases y-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J Neurochem 1993, 60:487-492.
57. Bymaster F., Perry K.W., Nelson D.L., Wong D.T., Rasmussen K., Moore N.A., et al. Olanzapine: a basic science update. Br J Psychiatry Suppl 1999, 37:36-40. [Review].
58. Bymaster F.P., Nelson D.L., DeLapp N.W., Falcone J.F., Eckols K., Truex L.L., et al. Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. Schizophr Res 1999, 37:107-122.
59. Kapur S., Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics. A new hypothesis. Am J Psychiatry 2001, 158:360-369.
60. Kapur S., Zipursky R.B., Remington G., Jones C., DaSilva J., WilsonA.A.Houle S. 5-HT2 and D2 receptor occupancy of olanzapine inschizophrenia: a PET investigation. Am J Psychiatry 1998, 155:921-928.
61. Furuya Y., Kagaya T., Ogura H., Nishizawa Y. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice. Eur J. Pharmacol 1999, 364:133-140.